Web暨南大学,数字图书馆. 开馆时间:周一至周日7:00-22:30 周五 7:00-12:00; 我的图书馆 WebOct 30, 2016 · 目的回顾性分析对比研究实体瘤疗效评价标准1.1版(Response Evaluation Criteria in Solid Tumors1.1,RECIST 1.1)和修改后实体瘤疗效评价标准(modified …
临床招募丨一项在广泛期小细胞肺癌受试者中比较 MK-7684A 联合 …
Web1.四川大学华西医院头颈肿瘤科,成都 610041;2.口腔疾病研究国家重点实验室 国家口腔疾病临床医学研究中心四川大学华西口腔医院头颈肿瘤外科,成都 610041;3.上海交通大学医学院附属第九人民医院口腔颌面头颈肿瘤外科,上海 200011;4.重庆医科大学附属第一 ... WebConclusion: iRECIST criteria were established by expert consensus; however, sufficient data for final validation has not yet been collected. As a result, RECIST 1.1 should be the … location national rouyn
[Comparison of RECIST 1.1 and iRECIST for Response Evaluation …
Weblesion size at baseline in irRECIST is aligned with RECIST 1.1, as outlined in Nishino et al., 2013. WHO 5.1.2 Unmeasurable Disease There are many forms of unmeasurable disease, and only a few are mentioned as examples: Lymphangitic pulmonary metastases. Skin involvement in breast cancer. Abdominal masses that can be palpated but not measured. … WebConclusions The use of irRECIST identified a subset of patients with a BOR of PD by RECIST 1.1 but an irBOR of immune-related disease control by irRECIST with a distinctive survival curve, thereby providing more clinically relevant information than RECIST 1.1 alone. However, as a surrogate endpoint for OS in the whole population, immune-related PFS by … WebConclusions The use of irRECIST identified a subset of patients with a BOR of PD by RECIST 1.1 but an irBOR of immune-related disease control by irRECIST with a distinctive survival … location netflix